PL EN


Preferences help
enabled [disable] Abstract
Number of results
2018 | 72(5) | 1-8
Article title

Bacterial lysates in the prevention of respiratory tract infections

Content
Title variants
Languages of publication
Abstracts
EN
Bacterial lysates stimulate the general immunity of the body in a non-specific way. They act on non-specific defense mechanisms, leading to an increase in type A antibody in mucous membranes, phagocytic activity and INF-ƴ production. They can also stimulate the production of specific antibodies against the bacterial antigens that make up the preparation. The oral immunomodulatory preparations with the best documented clinical efficacy available on the Polish market are Ismigen, Broncho-Vaxom, Ribomunyl and Luivac. They are all lysates of bacterial strains that most often cause respiratory tract infections. In many clinical trials, oral bacterial lysates have been shown to minimize the risk of recurrent respiratory infections in children and adults and reduce the need for antibiotics.
Year
Volume
Pages
1-8
Physical description
Dates
published
2018-11-06
Contributors
References
Document Type
Publication order reference
Identifiers
YADDA identifier
bwmeta1.element.ceon.element-bafb54ed-b650-3dd2-ab25-499add0b95b2
JavaScript is turned off in your web browser. Turn it on to take full advantage of this site, then refresh the page.